Clipping of news on Brazilian Culture, Law and Citizenship
05/10/2016
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
Anvisa
Anvisa determined the suspension of the distribution, marketing and use of lots R1503226, R1503227 and R1503228 the drug Digliconato Chlorhexidine 2%, 100 ml, Riohex brand. The product is manufactured by Pharmaceutical Industry Rioquímica Ltda.
The company voluntarily reported to Anvisa the recall of the product after checking the color change of the lots cited.
The Agency determined that the company promotes the collection of existing units on the market.
The measure is in Resolution RE 1137/2016, published Friday (06/05) in the Official Gazette (DOU).
Source: Anvisa
To access the Anvisa site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.